InspireMD Inc. (NSPR) - Cash per Single Share

The premium positioning of innovative stents allows InspireMD, Inc. (NSPR) to maintain pricing power despite pressure from hospital purchasing organizations. The dynamics of the liquid position per share, with the latest mark at 0.36, reveal the company's fundamental resilience. Capital is generated through the sale of CGuard systems for stroke prevention, while future growth relies on insurance reimbursement and the success of clinical trials.
Comprehensive metric breakdowns and analytics for InspireMD Inc. (NSPR)

InspireMD, Inc. (NSPR) holds a leading position in the carotid artery segment thanks to its innovative CGuard coating. By analyzing the cash per share trend, one can assess the company's liquid reserve per security. This metric determines the volume of free cash available to cover liabilities or fund growth. While the stability of this indicator reduces risk, it may suggest an underutilization of capital. For a conservative investor, such price action confirms the issuer's financial stability.